02/18/2014 - 11:33am

While flu activity declined slightly from the week prior, incidence of influenza-like illness rates remained above the national baseline for the week ended Feb. 8, the Centers for Disease Control and Prevention reported.

02/18/2014 - 10:05am

McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals.

02/18/2014 - 9:24am

Actavis and Forest Labs. announced that they have entered into a definitive agreement under which Actavis will acquire Forest for a combination of cash and equity valued at approximately $25 billion, or $89.48 per Forest share ($26.04 in cash and 0.3306 Actavis shares for each share of Forest common stock).

02/13/2014 - 12:40pm

After meeting for two days earlier this week, the Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 16-9 against changing the label of naproxen to highlight a lower cardiovascular risk profile as compared to other NSAIDs, according to published reports.

02/12/2014 - 12:34pm

Mallinckrodt and Cadence Pharmaceuticals on Tuesday announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals for $14.00 per share in cash.

02/11/2014 - 11:22am

The Generic Pharmaceutical Association announced its support of Georgia SB 370, introduced by pharmacist and Sen. Buddy Carter, R-Ga. District 1, because it will allow unimpeded patient access to interchangeable biologics.

02/10/2014 - 12:16pm

According to last week’s FluView report, released Friday, influenza activity remains elevated nationally.

02/10/2014 - 12:07pm

The Healthcare Distribution Management Association on Saturday announced the promotion of six staff members.

02/07/2014 - 4:54pm

Selecting a doctor can be a frustrating process filled with too many unknowns, especially in today’s evolving landscape.